Viracta Therapeutics News

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROYSTON IVOR

Sep 12 18:14 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger

Sep 12 18:14 ET

Viracta Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14 16:12 ET

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 14 07:19 ET

Viracta Therapeutics | 8-K: Current report

Jul 29 13:04 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROYSTON IVOR

Jun 24 19:56 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Borellini Flavia

Jun 24 19:51 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chung Jane

Jun 24 19:51 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Murphy Samuel Lafayette

Jun 24 19:51 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DARCY THOMAS E

Jun 24 19:50 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Simon Barry J.

Jun 24 19:46 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barlow Jane F

Jun 24 19:46 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger

Jun 24 19:45 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rubino Stephen

Jun 24 19:41 ET

Viracta Therapeutics | 8-K: Current report

Jun 20 16:13 ET

Viracta Therapeutics | 8-K: Current report

May 31 16:51 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger

May 29 19:13 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROYSTON IVOR

May 29 19:13 ET

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Faerm Michael E.

May 16 16:32 ET

Viracta Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Faerm Michael E.

May 16 16:28 ET